Qiagen-Abbott HPV, HIV, HCV Pact Expands PCR-Based Test Menu for Both Companies

The companies also said that they have separately resolved a lawsuit filed by Abbott against Qiagen earlier this year related to intellectual property surrounding PCR-based methods for detecting human papillomavirus.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.